Dr. Garrison’s research is focused on developing new approaches
to diagnose and treat rare diseases. His research builds on over 15 years of
experience in both industry and academia in areas of sensory biology and pain, Phelan-McDermid
syndrome, Fragile-X syndrome, Huntington’s disease, trichotillomania, and sickle
Prior to joining the Aurora Research Institute, Dr. Garrison held senior positions in rare disease drug development and biotech consulting. These experiences laid the foundation for his current efforts to repurpose drugs for rare disease. His prior research also focused on better understanding touch receptors in the skin, such as the transient receptor potential channels TRPA1 and TRPC1, as well as the involvement of keratinocytes and Nav1.8 in sensing touch, temperature and pain.
Dr. Garrison currently serves as the Wisconsin State Leader for the National Organization for Rare Disorders (NORD) and heads Rare Disease Day for the state.